Biotech · Private company
Kashiv BioSciences, LLC
Track this companyFree. Adds Kashiv BioSciences, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- Omalizumab InjectionPhase 3 · Chronic Idiopathic UrticariaClinicalTrials.gov · fetched Nov 12, 2026
- Xolair Prefilled SyringePhase 3 · Chronic Idiopathic UrticariaClinicalTrials.gov · fetched Nov 12, 2026
- FulvestrantPhase 1 · Healthy Postmenopausal WomenClinicalTrials.gov · fetched Nov 12, 2026
- KSHN001034Phase 1 · Healthy Postmenopausal WomenClinicalTrials.gov · fetched Nov 12, 2026
- TPI-120 Pre-Filled Syringe 6 mg/0.6 mLPhase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KSHN001034 in Healthy Postmenopausal Female VolunteersPHASE1 · RECRUITING · started Aug 18, 2025ClinicalTrials.gov NCT06995482 · fetched Nov 12, 2026
- Pharmacokinetic, Immunogenicity, and Safety Evaluation of Pegfilgrastim TPI-120 in Healthy AdultsPHASE1 · COMPLETED · started Apr 5, 2025ClinicalTrials.gov NCT07416955 · fetched Nov 12, 2026
- Study to Compare Efficacy Safety and Immunogenicity of ADL-018 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic UrticariaPHASE3 · COMPLETED · started Aug 15, 2023ClinicalTrials.gov NCT05774639 · fetched Nov 12, 2026